Trust and risk perception influence brain activity in health assessments

Perceiving whether another person is a personal health risk requires quickly assessing their trustworthiness.

Pharmalittle: We’re reading about an AstraZeneca deal, a WHO pandemic pact, and more

Rise and shine, everyone, another busy day is on the way. Already, the official mascots are racing about the Pharmalot campus in search of breakfast

March 19, 2024

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the

August 2, 2024

Iptacopan hydrochloride by Novartis for Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.